NCCAM Announces Complementary and Alternative Medicine and Oncology Fellowship
For Immediate Release:
NCCAM Press Office, 301-496-7790
The National Center for Complementary and Alternative Medicine (NCCAM), the National Cancer Institute (NCI), and the Food and Drug Administration’s Center for Drug Evaluation and Research have created a unique 3-year fellowship for new researchers to gain expertise in complementary and alternative medicine (CAM) and cancer.
CAM approaches are increasingly being used by people with cancer and their practitioners to address medical, psychosocial, and spiritual needs. Medical oncologists are frequently asked for their opinion on the use, benefits, and risks of CAM practices in the treatment of cancer. Because of the high use of CAM by cancer patients, more basic and clinical research is needed.
Fellows will be trained both in medical oncology and CAM and will be exposed to clinical and regulatory aspects unique to this field.
Eligible candidates are oncology fellows at NCI or at another accredited fellowship program in the U.S., who are completing their first clinical year.
Part of the National Institutes of Health, the mission of the National Center for Complementary and Alternative Medicine (NCCAM) is to define, through rigorous scientific investigation, the usefulness and safety of complementary and alternative medicine interventions and their roles in improving health and health care. For additional information, call NCCAM’s Clearinghouse toll free at 1-888-644-6226, or visit the NCCAM Web site at nccam.nih.gov. Follow us on Twitter, Facebook, and YouTube.